Effectiveness Similar for First-Line ACE Inhibitors, ARBs in HTN
Risks for angioedema, cough, pancreatitis, and GI bleeding significantly lower with ARBs for first-line HTN treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.